Data gathered: November 23
AI Stock Analysis - Angiodynamic (ANGO)
Analysis generated July 17, 2024. Powered by Chat GPT.
Angiodynamic is a medical device company specializing in the design and manufacturing of products for minimally invasive vascular access, surgery, peripheral vascular disease, and oncology. The company's product portfolio includes a variety of catheters, angiographic products, and other medical devices. Angiodynamic has a significant presence in the healthcare sector, serving hospitals and healthcare providers worldwide.
Stock Alerts - Angiodynamic (ANGO)
 |
Angiodynamic | November 6 Price is up by 5% in the last 24h. |
|
Angiodynamic | October 25 Price is down by -5.1% in the last 24h. |
|
Angiodynamic | October 23 Employee Rating is down by 2.9% over the last month. |
|
Angiodynamic | October 22 Price is up by 9.1% in the last 24h. |
Alternative Data for Angiodynamic
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 23 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 15,000 | Sign up | Sign up | Sign up |
| Employee Rating | 66 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | 38 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 1 | Sign up | Sign up | Sign up |
| Facebook Followers | 871 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 869 | Sign up | Sign up | Sign up |
| Twitter Followers | 1,499 | Sign up | Sign up | Sign up |
| Twitter Mentions | 10 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 1,670 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 40 | Sign up | Sign up | Sign up |
| Linkedin Employees | 949 | Sign up | Sign up | Sign up |
About Angiodynamic
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally.
| Price | $6.83 |
| Target Price | Sign up |
| Volume | 389,720 |
| Market Cap | $278M |
| Year Range | $5.27 - $7.84 |
| Dividend Yield | 0% |
| PE Ratio | 41.4 |
| Analyst Rating | 100% buy |
| Industry | Medical & Dental Instruments |
In the news
 |
Wall Street Analysts Believe AngioDynamics (ANGO) Could Rally 94.32%: Here's is How to TradeOctober 31 - Yahoo |
 |
Investors in AngioDynamics (NASDAQ:ANGO) have unfortunately lost 77% over the last three yearsOctober 29 - Yahoo |
AngioDynamics (ANGO) Stock Dips Amidst Financial Performance ReviewOctober 24 - GuruFocus |
|
 |
ANGO Stock Rises Following the Receipt of CPT Category I Code for IREOctober 23 - Yahoo |
Analysts Offer Insights on Healthcare Companies: Incyte (INCY), Otsuka Holdings Co (OtherOTSKF) and AngioDynamics (ANGO)October 22 - TipRanks |
|
AngioDynamics (ANGO) Stock Surges Amid Positive Analyst RatingsOctober 21 - GuruFocus |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 67M | 78M | 37M | -13M | -6.3M | -0.110 |
| Q2 '24 | 124M | 16M | 39M | -13M | -7.9M | -0.060 |
| Q1 '24 | 76M | 247M | 36M | -188M | -193M | -0.160 |
| Q4 '23 | 80M | 77M | 40M | -29M | -6.5M | -0.050 |
| Q3 '23 | 79M | 84M | 40M | 46M | 41M | -0.120 |
Insider Transactions View All
| Nighan Warren JR filed to buy 45,877 shares at $6.1. October 10 '24 |
| Trowbridge Stephen A filed to buy 172,711 shares at $5.9. October 8 '24 |
| Nighan Warren JR filed to buy 45,777 shares at $6.1. October 10 '24 |
| Clemmer James C filed to buy 681,582 shares at $6. October 8 '24 |
| Clemmer James C filed to buy 539,066 shares at $6.7. April 8 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Align TechnologyALGN |
$225.89 0% | 48 |
 |
DentsplyXRAY |
$18.77 0% | 46 |
 |
LeMaitre VascularLMAT |
$107.97 0% | 42 |
 |
iRhythm TechnologiesIRTC |
$73.99 0% | 41 |
 |
NovoCureNVCR |
$17.73 0% | 57 |
Read more about Angiodynamic (ANGO) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Angiodynamic?
The Market Cap of Angiodynamic is $278M.
What is Angiodynamic's PE Ratio?
As of today, Angiodynamic's PE (Price to Earnings) ratio is 41.4.
What is the current stock price of Angiodynamic?
Currently, the price of one share of Angiodynamic stock is $6.83.
How can I analyze the ANGO stock price chart for investment decisions?
The ANGO stock price chart above provides a comprehensive visual representation of Angiodynamic's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Angiodynamic shares. Our platform offers an up-to-date ANGO stock price chart, along with technical data analysis and alternative data insights.
Does ANGO offer dividends to its shareholders?
As of our latest update, Angiodynamic (ANGO) does not offer dividends to its shareholders. Investors interested in Angiodynamic should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Angiodynamic?
Some of the similar stocks of Angiodynamic are Align Technology, Dentsply, LeMaitre Vascular, iRhythm Technologies, and NovoCure.
.